Sundar PichaiSundar Pichai earned $164M in 2023

Christian O. Henry is the CEO of Pacific Biosciences of California, Inc. He has a strong background that blends science and business. He earned his B.A. in Biochemistry and Cell Biology from the University of California, San Diego, then furthered...

Quick Links
P

Christian O. Henry

CEO of Pacific Biosciences of California

Education

B.A. in Biochemistry and Cell Biology from the University of California, San Diego; M.B.A. with a concentration in finance from the University of California, Irvine.

Field of Expertise

Business & Management - Business

Sector of Economy

Healthcare

CEO of Pacific Biosciences of California for

4 years 6 months (Sep 2020 - Present)

Previous Experience

Executive Vice President & Chief Commercial Officer of Illumina, Inc.; various senior roles at Affymetrix, Inc., and Nektar Therapeutics.

Holdings

See how much did Christian O. Henry make over time.

Christian O. Henry has had significant moments in his stock holdings, especially after becoming CEO in September 2020. His trading activity peaked in 2021, when his holdings were valued over $37 million, marking a high point in confidence during an...

Total Stock Sold

$69.64M

ILMN

$57.47M

549,244 ILMN shares

DNA

$12.14M

3,674.625 DNA shares

PACB

$23.41K

2,122 PACB shares

What if they kept their stock?

If Christian O. Henry didn't sell their stock, today they would have:
Extra ILMN549,244 shares worth $154.33M and DNA3,674.625 shares worth $1.79M and PACB2,122 shares worth $6.37K.
This is 124.2% and $86.49M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Christian O. Henry.

WVE

16,115 shares

WVE

Aug 12, 2024

Received

DNA

$6.26K

DNA at $1.39/share

Nov 2, 2023

Sale

DNA

$8.01K

DNA at $1.78/share

Oct 2, 2023

Sale

DNA

$20.24M

DNA at $4.50K/share

Oct 2, 2023

Sale

Compensation History

See how much did Christian O. Henry make over time.

In 2023, Christian O. Henry's total compensation at Pacific Biosciences was around $7 million, which showcased a robust performance-based salary. This was due to a combination of his base salary and a substantial bonus linked directly to key performance targets in revenue and cash balance. He had a vested stock award of about $5.8 million, indicating confidence in the company’s stock value. The previous years also showed impressive figures; in 2022, he earned over $6 million, indicating a steady increase in his remuneration in response to the company's growth. Additionally, his total compensation has always reflected a performance-driven approach, aligning his interests closely with the company's success and encouraging his team to reach ambitious targets.

Year

2023

Total Compensation

$7.22M

Salary

$700.15K

Board Justification

The compensation philosophy is designed to align executive compensation with company performance, attract and retain key talent, and motivate executives to achieve short-term and long-term corporate objectives.

Bonus

$700.15K

Board Justification

The bonus is based on the achievement of certain pre-established performance criteria, including revenue and cash balance targets, with a payout of 100% of the target bonus opportunity due to meeting these goals in 2023.

Other

$15.29K

Board Justification

Other compensation includes travel and lodging costs covered by the Company for participation in a sales incentive trip.

Restricted Stock

$5.81M(594.69K RSU)

Board Justification

The stock awards consist of RSUs that vested in 2023, with the total number of shares vested being 594,687.

Performance Metrics

The performance metrics include revenue targets and cash balance goals, with specific thresholds for bonus payouts.

Other Pacific Biosciences of California CEOs

Here are other CEOs of Pacific Biosciences of California